Member Info for Ssccss

What are others thoughts on an exit strategy?

I don't think it would go bust personally but it may just become a shell, bot not able to progress much without funding. Or maybe they will sell their IP to another small company started by similar people. I don't think Vlad will sell to large pharma. Who knows.

Nearly 10% down now. It's unrelenting.

*Buy

I obviously can't even bring myself to type the word...

Anon, why would you be tempted to by when we are probably in the middle of another conversion? The SP hasn't stabilised yet.

Why do you keep singling out tuan. It's very much like bullying. Luckily, tuan seems unphased. This is a public forum Filter him or don't come here.

All the blue trades today? We are currently down 4.47%.

I don't think it's necessarily that Vlad doesn't want to help. He has tried with the interview, the RNS and the TMS article. The fact is, they haven't been effective. It doesn't seem like he has anything he can offer right now which will prevent the decline of the SP.

I'd much rather miss the bottom than lose 50% if this goes to 1p. Have to be realistic.

Agree Bo, I have 11k to invest. Can't see it going into hemo until Mint is gone and investor relations are improved.

Are you choosing to ignore that we are now at the same SP as pre-covid? And not much further ahead in terms of research progress. The rise in SP last year was due to covid. Arguably, Hemo is now much worse off because it has lost the opportunity of Global taking CDX option and it now has CLN. The recent article by TMS has also tried to play down the covid influence. So that makes me wonder if there is nothing to see there with CBX or whatever the catchy name is.

JHFH, it's not just tuan that sees little value in pre clinical intellectual property. It's the whole market, including potential funders. Otherwise, Hemo would not be in this situation! That's the whole point of clinical trials, to prove the value. Wow, it's not tuan who has a lack of understanding of scientific trials.

IMO, tuan just says it like it is. There are many other posters that are/were full of ****.

Like you said, time will tell.

One question, if you don't think there is a problem with investor relations, why are people not buying into hemo at the moment? It's down 75% since the start of the year. Why didn't the interview, final results RNS and TMS article have any discernable impact on the SP? The issue isn't just Mint, it is a combination of factors all come home to roost together.

By traders, I mean the ones who sycophantically crawl over his tweets and ramp.

I truly hope you are right Hedge, for everyone invested here. However, whichever you look at it, at the moment the maths just doesn't add up. Where is the funding going to come from? That is the most important question. This is very serious for Hemo and I do not share your confidence at all. But each to their own. It's your money.

On top of everything else, they now have a massive PR issue with investors. The tweets, the hype, the opaque RNS's, the CLN trashing existing shareholder value and recently inferring somehow this situation is due to impatient investors. It was always apparent that Vlad wasn't a fan of traders/investors but this shows a complete lack of awareness of the implications.

Unless they change the nominal value of the shares but I really can't see how that will help. Surely, it would just cause more damage.

Mint must be concerned too. I wonder if Mint and Hemo just thought private investors would gobble up all the shares even though we have no confirmed advances in research, global co not taking the option and highly significant levels of dilution. Must think we are daft.

Agree Shear. I don't know how they will complete the rest of the conversions for the £8.1m. It doesn't seem possible at this stage.